TOI ONCOLOGY INSTITUTE INC (THE)

MaxHealth & The Oncology Institute Expand Value-Based Care Partnership

MaxHealth & The Oncology Institute Expand Value-Based Care Partnership

TOI announces clinical and financial accountability for MaxHealth Oncology Care in 5 Florida Counties

CERRITOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), a leading value-based oncology group, and MaxHealth, an innovative leader in value-based primary care, have announced a comprehensive new agreement. Under this full-risk arrangement, TOI will assume clinical and financial responsibility for all oncology care provided to patients in Pinellas, Hillsborough, Polk, Broward, and Miami-Dade Counties. This innovative payment model aligns seamlessly with MaxHealth's existing value-based care agreements with large managed care organizations.

“We are excited to strengthen our partnership with MaxHealth, a distinguished primary care organization,” expressed Dr. Daniel Virnich, TOI’s Chief Executive Officer. “MaxHealth’s outstanding reputation in care coordination and services harmonizes perfectly with our commitment to outstanding community-based oncology. We are confident that our care model is well-suited to deliver exceptional care to their patients.”

TOI employs an outcomes and quality-based incentive model to enhance patient satisfaction and clinical results By bringing cutting-edge cancer care to the community setting, TOI is transforming the delivery of specialty care.

“We are thrilled to collaborate with TOI to offer best-in-class cancer care for our patients,” added Dr. Paul Kaplan, Chief Medical Officer of MaxHealth. “TOI shares our commitment to personalized care and patient satisfaction – we know our patients will be in good hands.”

About The Oncology Institute

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced healthcare organizations. With 110+ employed clinicians and more than 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit

About MaxHealth

The MaxHealth Network is a network of primary care facilities for adults and seniors with over 50 locations throughout Florida. MaxHealth is reinventing the healthcare experience. With a focus on value-based care and provider-patient relationships, our patients experience advanced medical care, delivered by highly-trained, board-certified physicians who treat their patients like family. From caregivers to staff, MaxHealth is devoted to the patient experience. It’s personal to us… it matters. From a friendly greeting at the front desk to a doctor taking extra time to really listen to the patient, this approach can be felt throughout the company.

Investors

Solebury Strategic Communications



EN
14/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONCOLOGY INSTITUTE INC (THE)

 PRESS RELEASE

The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminar...

The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook CERRITOS, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based oncology groups in the United States, today reaffirmed 2025 guidance and provided its preliminary 2026 outlook. 2026 Outlook For 2026, TOI anticipates that total revenue will be in the range of $630 million to $650 million, reflecting 28% growth from the midpoint of 2025 and 2026 guidance ranges, and including approximately $150 million of Capitation rev...

 PRESS RELEASE

The Oncology Institute Announces Leadership Promotions

The Oncology Institute Announces Leadership Promotions Rakesh Panda appointed Chief Information Officer Nolan Mariano appointed Chief People Officer CERRITOS, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) announced today the promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer. These promotions reinforce TOI’s continued focus on leading the way in value-based cancer care through further development of our technology-enabled care delivery platform as well as strengthening our mission-oriented culture supp...

 PRESS RELEASE

The Oncology Institute Announces Addition of Board Member Mark Stolper

The Oncology Institute Announces Addition of Board Member Mark Stolper CERRITOS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Mark Stolper has joined the Board of Directors, effective January 2, 2026. Mr. Stolper brings significant public markets, financial and operational leadership experience to The Oncology Institute’s board. Mr. Stolper serves as Executive Vice President and Chief Financial Officer of RadNet, Inc. (NASDAQ: RDNT), a position he has ...

 PRESS RELEASE

The Oncology Institute Announces Resignation of Board Member Gabe Ling

The Oncology Institute Announces Resignation of Board Member Gabe Ling CERRITOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Gabe Ling has resigned from the Board of Directors, effective December 1, 2025. A formal search process has been initiated to add new independent directors with complementary healthcare, clinical, and value-based care expertise. “On behalf of the Board of Directors, I want to thank Gabe for his service during an important chapt...

 PRESS RELEASE

The Oncology Institute Reports Third Quarter 2025 Financial Results an...

The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended September 30, 2025 and updated its full year 2025 guidance. Recent Operational Highlights Fee-for-service revenue growth of 13% over Q3 2024, driven by continued organic growth performance in Florida and Oregon.Retail Pharmacy ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch